XML 90 R38.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Guarantor and Non-Guarantor Financial Statements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2015
Guarantor and Non-Guarantor Financial Statement [Abstract] |
Schedule of Condensed Financial Statements | CONDENSED CONSOLIDATING BALANCE SHEET (In millions of dollars) September 30, 2015
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
ASSETS |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | — |  |  | $ | 79.6 |  |  | $ | 3.0 |  |  | $ | — |  |  | $ | 82.6 |
Short-term investments |  | — |  |  | 30.0 |  |  | — |  |  | — |  |  | 30.0 |
Receivables: |  |  |  |  |  |  |  |  |  |
Trade receivables — net |  | — |  |  | 127.8 |  |  | 3.8 |  |  | — |  |  | 131.6 |
Intercompany receivables |  | 29.2 |  |  | 96.8 |  |  | 2.6 |  |  | (128.6 | ) |  | — |
Other |  | — |  |  | 2.1 |  |  | 2.3 |  |  | — |  |  | 4.4 |
Inventories |  | — |  |  | 213.7 |  |  | 6.0 |  |  | (2.4 | ) |  | 217.3 |
Prepaid expenses and other current assets |  | 0.1 |  |  | 98.1 |  |  | 1.3 |  |  | (0.9 | ) |  | 98.6 |
Total current assets |  | 29.3 |  |  | 648.1 |  |  | 19.0 |  |  | (131.9 | ) |  | 564.5 |
Investments in and advances to subsidiaries |  | 1,057.2 |  |  | 32.3 |  |  | — |  |  | (1,089.5 | ) |  | — |
Property, plant and equipment — net |  | — |  |  | 444.2 |  |  | 28.5 |  |  | — |  |  | 472.7 |
Long-term intercompany receivables |  | — |  |  | — |  |  | 2.4 |  |  | (2.4 | ) |  | — |
Deferred tax assets — net |  | — |  |  | 128.6 |  |  | — |  |  | 7.1 |  |  | 135.7 |
Intangible assets — net |  | — |  |  | 30.9 |  |  | — |  |  | — |  |  | 30.9 |
Goodwill |  | — |  |  | 37.2 |  |  | — |  |  | — |  |  | 37.2 |
Other assets |  | 3.7 |  |  | 18.3 |  |  | 0.1 |  |  | — |  |  | 22.1 |
Total |  | $ | 1,090.2 |  |  | $ | 1,339.6 |  |  | $ | 50.0 |  |  | $ | (1,216.7 | ) |  | $ | 1,263.1 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 0.7 |  |  | $ | 64.1 |  |  | $ | 4.5 |  |  | $ | — |  |  | $ | 69.3 |
Intercompany payable |  | 92.3 |  |  | 42.6 |  |  | 3.8 |  |  | (138.7 | ) |  | — |
Accrued salaries, wages and related expenses |  | — |  |  | 35.5 |  |  | 2.9 |  |  | — |  |  | 38.4 |
Other accrued liabilities |  | 6.0 |  |  | 55.6 |  |  | 0.7 |  |  | (0.9 | ) |  | 61.4 |
Short-term capital lease |  | — |  |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Total current liabilities |  | 99.0 |  |  | 197.9 |  |  | 11.9 |  |  | (139.6 | ) |  | 169.2 |
Net liabilities of Salaried VEBA |  | — |  |  | 15.9 |  |  | — |  |  | — |  |  | 15.9 |
Deferred tax liabilities |  | — |  |  | — |  |  | 0.8 |  |  | — |  |  | 0.8 |
Long-term intercompany payable |  | — |  |  | 2.4 |  |  | — |  |  | (2.4 | ) |  | — |
Long-term liabilities |  | — |  |  | 80.9 |  |  | 5.1 |  |  | — |  |  | 86.0 |
Long-term debt |  | 218.9 |  |  | — |  |  | — |  |  | — |  |  | 218.9 |
Total liabilities |  | 317.9 |  |  | 297.1 |  |  | 17.8 |  |  | (142.0 | ) |  | 490.8 |
Total stockholders’ equity |  | 772.3 |  |  | 1,042.5 |  |  | 32.2 |  |  | (1,074.7 | ) |  | 772.3 |
Total |  | $ | 1,090.2 |  |  | $ | 1,339.6 |  |  | $ | 50.0 |  |  | $ | (1,216.7 | ) |  | $ | 1,263.1 |
CONDENSED CONSOLIDATING BALANCE SHEET (In millions of dollars) December 31, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
ASSETS |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | — |  |  | $ | 175.3 |  |  | $ | 2.4 |  |  | $ | — |  |  | $ | 177.7 |
Short-term investments |  | — |  |  | 114.0 |  |  | — |  |  | — |  |  | 114.0 |
Receivables: |  |  |  |  |  |  |  |  |  |
Trade receivables — net |  | — |  |  | 126.1 |  |  | 3.2 |  |  | — |  |  | 129.3 |
Intercompany receivables |  | 204.2 |  |  | 4.0 |  |  | 0.9 |  |  | (209.1 | ) |  | — |
Other |  | — |  |  | 5.6 |  |  | 5.3 |  |  | — |  |  | 10.9 |
Inventories |  | — |  |  | 208.0 |  |  | 7.6 |  |  | (0.9 | ) |  | 214.7 |
Prepaid expenses and other current assets |  | 85.1 |  |  | 93.1 |  |  | 0.4 |  |  | — |  |  | 178.6 |
Total current assets |  | 289.3 |  |  | 726.1 |  |  | 19.8 |  |  | (210.0 | ) |  | 825.2 |
Investments in and advances to subsidiaries |  | 1,209.2 |  |  | 32.5 |  |  | — |  |  | (1,241.7 | ) |  | — |
Property, plant and equipment — net |  | — |  |  | 437.4 |  |  | 17.5 |  |  | — |  |  | 454.9 |
Long-term intercompany receivables |  | — |  |  | — |  |  | 15.9 |  |  | (15.9 | ) |  | — |
Net assets of Union VEBA |  | — |  |  | 340.1 |  |  | — |  |  | — |  |  | 340.1 |
Deferred tax assets — net |  | — |  |  | 23.8 |  |  | — |  |  | 7.1 |  |  | 30.9 |
Intangible assets — net |  | — |  |  | 32.1 |  |  | — |  |  | — |  |  | 32.1 |
Goodwill |  | — |  |  | 37.2 |  |  | — |  |  | — |  |  | 37.2 |
Other assets |  | 4.4 |  |  | 18.8 |  |  | 0.1 |  |  | — |  |  | 23.3 |
Total |  | $ | 1,502.9 |  |  | $ | 1,648.0 |  |  | $ | 53.3 |  |  | $ | (1,460.5 | ) |  | $ | 1,743.7 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 1.3 |  |  | $ | 73.8 |  |  | $ | 6.3 |  |  | $ | — |  |  | $ | 81.4 |
Intercompany payable |  | — |  |  | 221.3 |  |  | 3.3 |  |  | (224.6 | ) |  | — |
Accrued salaries, wages and related expenses |  | — |  |  | 36.5 |  |  | 3.1 |  |  | — |  |  | 39.6 |
Other accrued liabilities |  | 88.2 |  |  | 43.8 |  |  | 0.8 |  |  | — |  |  | 132.8 |
Current portion of long-term debt |  | 172.5 |  |  | — |  |  | — |  |  | — |  |  | 172.5 |
Short-term capital lease |  | — |  |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Total current liabilities |  | 262.0 |  |  | 375.5 |  |  | 13.5 |  |  | (224.6 | ) |  | 426.4 |
Net liabilities of Salaried VEBA |  | — |  |  | 17.2 |  |  | — |  |  | — |  |  | 17.2 |
Deferred tax liabilities |  | — |  |  | — |  |  | 0.9 |  |  | — |  |  | 0.9 |
Long-term intercompany payable |  | — |  |  | 15.9 |  |  | — |  |  | (15.9 | ) |  | — |
Long-term liabilities |  | — |  |  | 50.3 |  |  | 8.0 |  |  | — |  |  | 58.3 |
Long-term debt |  | 225.0 |  |  | — |  |  | — |  |  | — |  |  | 225.0 |
Total liabilities |  | 487.0 |  |  | 458.9 |  |  | 22.4 |  |  | (240.5 | ) |  | 727.8 |
Total stockholders’ equity |  | 1,015.9 |  |  | 1,189.1 |  |  | 30.9 |  |  | (1,220.0 | ) |  | 1,015.9 |
Total |  | $ | 1,502.9 |  |  | $ | 1,648.0 |  |  | $ | 53.3 |  |  | $ | (1,460.5 | ) |  | $ | 1,743.7 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) (In millions of dollars) Quarter Ended September 30, 2015
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 329.5 |  |  | $ | 29.4 |  |  | $ | (22.5 | ) |  | $ | 336.4 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 263.1 |  |  | 25.3 |  |  | (21.1 | ) |  | 267.3 |
Unrealized losses on derivative instruments |  | — |  |  | 1.7 |  |  | — |  |  | — |  |  | 1.7 |
Depreciation and amortization |  | — |  |  | 7.8 |  |  | 0.3 |  |  | — |  |  | 8.1 |
Selling, general, administrative, research and development: |  |  |  |  |  |  |  |  |  |
Selling, general, administrative, research and development |  | 0.9 |  |  | 18.4 |  |  | 2.4 |  |  | (0.6 | ) |  | 21.1 |
Net periodic postretirement benefit cost relating to Salaried VEBA |  | — |  |  | 0.6 |  |  | — |  |  | — |  |  | 0.6 |
Gain on removal of Union VEBA net assets |  | — |  |  | (2.9 | ) |  | — |  |  | — |  |  | (2.9 | )
Total selling, general, administrative, research and development |  | 0.9 |  |  | 16.1 |  |  | 2.4 |  |  | (0.6 | ) |  | 18.8 |
Total costs and expenses |  | 0.9 |  |  | 288.7 |  |  | 28.0 |  |  | (21.7 | ) |  | 295.9 |
Operating (loss) income |  | (0.9 | ) |  | 40.8 |  |  | 1.4 |  |  | (0.8 | ) |  | 40.5 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (4.7 | ) |  | (0.3 | ) |  | — |  |  | 0.1 |  |  | (4.9 | )
Other (expense) income, net |  | (0.6 | ) |  | 2.2 |  |  | (2.4 | ) |  | (0.1 | ) |  | (0.9 | )
(Loss) income before income taxes |  | (6.2 | ) |  | 42.7 |  |  | (1.0 | ) |  | (0.8 | ) |  | 34.7 |
Income tax (provision) benefit |  | — |  |  | (15.6 | ) |  | 0.8 |  |  | 2.2 |  |  | (12.6 | )
Earnings (loss) in equity of subsidiaries |  | 28.3 |  |  | (1.0 | ) |  | — |  |  | (27.3 | ) |  | — |
Net income (loss) |  | $ | 22.1 |  |  | $ | 26.1 |  |  | $ | (0.2 | ) |  | $ | (25.9 | ) |  | $ | 22.1 |
Comprehensive income (loss) |  | $ | 22.2 |  |  | $ | 26.5 |  |  | $ | (0.5 | ) |  | $ | (26.0 | ) |  | $ | 22.2 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE (LOSS) INCOME (In millions of dollars) Nine Months Ended September 30, 2015
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 1,051.2 |  |  | $ | 97.6 |  |  | $ | (73.5 | ) |  | $ | 1,075.3 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 848.9 |  |  | 85.8 |  |  | (70.3 | ) |  | 864.4 |
Unrealized loss on derivative instruments |  | — |  |  | 7.7 |  |  | — |  |  | — |  |  | 7.7 |
Depreciation and amortization |  | — |  |  | 23.3 |  |  | 0.9 |  |  | — |  |  | 24.2 |
Selling, general, administrative, research and development: |  |  |  |  |  |  |  |  |  |
Selling, general, administrative, research and development |  | 3.3 |  |  | 58.6 |  |  | 7.2 |  |  | (1.7 | ) |  | 67.4 |
Net periodic postretirement benefit cost relating to Salaried VEBA |  | — |  |  | 1.8 |  |  | — |  |  | — |  |  | 1.8 |
Loss on removal of Union VEBA net assets |  | — |  |  | 490.9 |  |  | — |  |  | — |  |  | 490.9 |
Total selling, general, administrative, research and development |  | 3.3 |  |  | 551.3 |  |  | 7.2 |  |  | (1.7 | ) |  | 560.1 |
Total costs and expenses |  | 3.3 |  |  | 1,431.2 |  |  | 93.9 |  |  | (72.0 | ) |  | 1,456.4 |
Operating (loss) income |  | (3.3 | ) |  | (380.0 | ) |  | 3.7 |  |  | (1.5 | ) |  | (381.1 | )
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (19.1 | ) |  | (1.1 | ) |  | — |  |  | 0.3 |  |  | (19.9 | )
Other (expense) income, net |  | (0.6 | ) |  | 3.0 |  |  | (2.2 | ) |  | (0.3 | ) |  | (0.1 | )
(Loss) income before income taxes |  | (23.0 | ) |  | (378.1 | ) |  | 1.5 |  |  | (1.5 | ) |  | (401.1 | )
Income tax benefit |  | — |  |  | 140.5 |  |  | 2.2 |  |  | 8.5 |  |  | 151.2 |
(Loss) earnings in equity of subsidiaries |  | (226.9 | ) |  | 2.2 |  |  | — |  |  | 224.7 |  |  | — |
Net (loss) income |  | $ | (249.9 | ) |  | $ | (235.4 | ) |  | $ | 3.7 |  |  | $ | 231.7 |  |  | $ | (249.9 | )
Comprehensive (loss) income |  | $ | (182.5 | ) |  | $ | (167.8 | ) |  | $ | 3.5 |  |  | $ | 164.3 |  |  | $ | (182.5 | )
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (In millions of dollars) Quarter Ended September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 330.3 |  |  | $ | 33.6 |  |  | $ | (25.0 | ) |  | $ | 338.9 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 274.7 |  |  | 29.8 |  |  | (24.1 | ) |  | 280.4 |
Unrealized gains on derivative instruments |  | — |  |  | 3.6 |  |  | — |  |  | — |  |  | 3.6 |
Depreciation and amortization |  | — |  |  | 7.7 |  |  | 0.3 |  |  | — |  |  | 8.0 |
Selling, general, administrative, research and development: |  |  |  |  |  |  |  |  |  |
Selling, general, administrative, research and development |  | 0.9 |  |  | 17.2 |  |  | 1.7 |  |  | (0.8 | ) |  | 19.0 |
Net periodic postretirement benefit income relating to VEBAs |  | — |  |  | (6.0 | ) |  | — |  |  | — |  |  | (6.0 | )
Total selling, general, administrative, research and development |  | 0.9 |  |  | 11.2 |  |  | 1.7 |  |  | (0.8 | ) |  | 13.0 |
Other operating charges, net |  | — |  |  | 1.3 |  |  | — |  |  | — |  |  | 1.3 |
Total costs and expenses |  | 0.9 |  |  | 298.5 |  |  | 31.8 |  |  | (24.9 | ) |  | 306.3 |
Operating (loss) income |  | (0.9 | ) |  | 31.8 |  |  | 1.8 |  |  | (0.1 | ) |  | 32.6 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (9.4 | ) |  | (0.5 | ) |  | — |  |  | 0.2 |  |  | (9.7 | )
Other income (expense), net |  | 2.2 |  |  | 0.3 |  |  | (0.1 | ) |  | (0.2 | ) |  | 2.2 |
(Loss) income before income taxes |  | (8.1 | ) |  | 31.6 |  |  | 1.7 |  |  | (0.1 | ) |  | 25.1 |
Income tax (provision) benefit |  | — |  |  | (11.9 | ) |  | (0.1 | ) |  | 2.8 |  |  | (9.2 | )
Earnings in equity of subsidiaries |  | 24.0 |  |  | 1.6 |  |  | — |  |  | (25.6 | ) |  | — |
Net income |  | $ | 15.9 |  |  | $ | 21.3 |  |  | $ | 1.6 |  |  | $ | (22.9 | ) |  | $ | 15.9 |
Comprehensive income |  | $ | 17.2 |  |  | $ | 22.5 |  |  | $ | 1.7 |  |  | $ | (24.2 | ) |  | $ | 17.2 |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (In millions of dollars) Nine Months Ended September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Net sales |  | $ | — |  |  | $ | 993.1 |  |  | $ | 100.7 |  |  | $ | (75.7 | ) |  | $ | 1,018.1 |
Costs and expenses: |  |  |  |  |  |  |  |  |  |
Cost of products sold: |  |  |  |  |  |  |  |  |  |
Cost of products sold, excluding depreciation and amortization and other items |  | — |  |  | 824.4 |  |  | 87.9 |  |  | (73.5 | ) |  | 838.8 |
Unrealized gains on derivative instruments |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Depreciation and amortization |  | — |  |  | 22.3 |  |  | 0.8 |  |  | — |  |  | 23.1 |
Selling, general, administrative, research and development: |  |  |  |  |  |  |  |  |  |
Selling, general, administrative, research and development |  | 3.1 |  |  | 52.3 |  |  | 7.9 |  |  | (2.0 | ) |  | 61.3 |
Net periodic postretirement benefit income relating to VEBAs |  | — |  |  | (17.7 | ) |  | — |  |  | — |  |  | (17.7 | )
Total selling, general, administrative, research and development |  | 3.1 |  |  | 34.6 |  |  | 7.9 |  |  | (2.0 | ) |  | 43.6 |
Other operating charges, net |  | — |  |  | 1.5 |  |  | — |  |  | — |  |  | 1.5 |
Total costs and expenses |  | 3.1 |  |  | 882.8 |  |  | 96.6 |  |  | (75.5 | ) |  | 907.0 |
Operating (loss) income |  | (3.1 | ) |  | 110.3 |  |  | 4.1 |  |  | (0.2 | ) |  | 111.1 |
Other (expense) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  | (28.0 | ) |  | (0.1 | ) |  | — |  |  | 0.4 |  |  | (27.7 | )
Other income, net |  | 3.6 |  |  | 2.3 |  |  | 0.4 |  |  | (0.4 | ) |  | 5.9 |
(Loss) income before income taxes |  | (27.5 | ) |  | 112.5 |  |  | 4.5 |  |  | (0.2 | ) |  | 89.3 |
Income tax (provision) benefit |  | — |  |  | (42.3 | ) |  | (0.9 | ) |  | 10.1 |  |  | (33.1 | )
Earnings in equity of subsidiaries |  | 83.7 |  |  | 3.4 |  |  | — |  |  | (87.1 | ) |  | — |
Net income |  | $ | 56.2 |  |  | $ | 73.6 |  |  | $ | 3.6 |  |  | $ | (77.2 | ) |  | $ | 56.2 |
Comprehensive income |  | $ | 60.5 |  |  | $ | 77.7 |  |  | $ | 3.8 |  |  | $ | (81.5 | ) |  | $ | 60.5 |
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (In millions of dollars) Nine Months Ended September 30, 2015
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |
Net cash provided by (used in) operating activities |  | $ | 250.2 |  |  | $ | (140.8 | ) |  | $ | (0.5 | ) |  | $ | — |  |  | $ | 108.9 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |
Capital expenditures |  | — |  |  | (26.0 | ) |  | (12.4 | ) |  | — |  |  | (38.4 | )
Purchase of available for sale securities |  | — |  |  | (0.5 | ) |  | — |  |  | — |  |  | (0.5 | )
Proceeds from disposition of available for sale securities |  | — |  |  | 84.0 |  |  | — |  |  | — |  |  | 84.0 |
Net cash provided by (used in) investing activities |  | — |  |  | 57.5 |  |  | (12.4 | ) |  | — |  |  | 45.1 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |
Repurchase of Senior Notes |  | (6.1 | ) |  | — |  |  | — |  |  | — |  |  | (6.1 | )
Settlement of Convertible Notes |  | (175.0 | ) |  | — |  |  | — |  |  | — |  |  | (175.0 | )
Proceeds from cash-settled call options related to settlement of Convertible Notes |  | 94.9 |  |  | — |  |  | — |  |  | — |  |  | 94.9 |
Payment for conversion premium related to settlement of Convertible Notes |  | (94.9 | ) |  | — |  |  | — |  |  | — |  |  | (94.9 | )
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest |  | — |  |  | 1.1 |  |  | — |  |  | — |  |  | 1.1 |
Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares |  | (3.0 | ) |  | — |  |  | — |  |  | — |  |  | (3.0 | )
Repurchase of common stock |  | (45.1 | ) |  | — |  |  | — |  |  | — |  |  | (45.1 | )
Cash dividend paid to stockholders |  | (21.0 | ) |  | — |  |  | — |  |  | — |  |  | (21.0 | )
Intercompany loan |  | — |  |  | (13.5 | ) |  | 13.5 |  |  | — |  |  | — |
Net cash (used in) provided by financing activities |  | (250.2 | ) |  | (12.4 | ) |  | 13.5 |  |  | — |  |  | (249.1 | )
Net (decrease) increase in cash and cash equivalents during the period |  | — |  |  | (95.7 | ) |  | 0.6 |  |  | — |  |  | (95.1 | )
Cash and cash equivalents at beginning of period |  | — |  |  | 175.3 |  |  | 2.4 |  |  | — |  |  | 177.7 |
Cash and cash equivalents at end of period |  | $ | — |  |  | $ | 79.6 |  |  | $ | 3.0 |  |  | $ | — |  |  | $ | 82.6 |
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (In millions of dollars) Nine Months Ended September 30, 2014
|  | Parent |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Consolidating Adjustments |  | Consolidated
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |
Net cash provided by operating activities |  | $ | 13.9 |  |  | $ | 82.7 |  |  | $ | 7.1 |  |  | $ | — |  |  | $ | 103.7 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |
Capital expenditures |  | — |  |  | (38.1 | ) |  | (1.5 | ) |  | — |  |  | (39.6 | )
Purchase of available for sale securities |  | — |  |  | (53.4 | ) |  | — |  |  | — |  |  | (53.4 | )
Proceeds from disposition of available for sale securities |  | — |  |  | 82.2 |  |  | — |  |  | — |  |  | 82.2 |
Change in restricted cash |  | — |  |  | (0.7 | ) |  | — |  |  | — |  |  | (0.7 | )
Net cash used in investing activities |  | — |  |  | (10.0 | ) |  | (1.5 | ) |  | — |  |  | (11.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest |  | — |  |  | 0.8 |  |  | — |  |  | — |  |  | 0.8 |
Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares |  | (2.4 | ) |  | — |  |  | — |  |  | — |  |  | (2.4 | )
Repurchase of common stock |  | (28.7 | ) |  | — |  |  | — |  |  | — |  |  | (28.7 | )
Cash dividend paid to stockholders |  | (19.1 | ) |  | — |  |  | — |  |  | — |  |  | (19.1 | )
Intercompany loan |  | 31.3 |  |  | (22.6 | ) |  | (8.7 | ) |  | — |  |  | — |
Net cash used in financing activities |  | (18.9 | ) |  | (21.8 | ) |  | (8.7 | ) |  | — |  |  | (49.4 | )
Net increase (decrease) in cash and cash equivalents during the period |  | (5.0 | ) |  | 50.9 |  |  | (3.1 | ) |  | — |  |  | 42.8 |
Cash and cash equivalents at beginning of period |  | 5.0 |  |  | 157.7 |  |  | 6.8 |  |  | — |  |  | 169.5 |
Cash and cash equivalents at end of period |  | $ | — |  |  | $ | 208.6 |  |  | $ | 3.7 |  |  | $ | — |  |  | $ | 212.3 |

X
- Definition Guarantor and Non-Guarantor Financial Statement [Abstract] + References No definition available. + Details
Name: | kalu_GuarantorAndNonGuarantorFinancialStatementAbstract
Namespace Prefix: | kalu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration